Synedica FAQ

Synedica Peptides is a UK-based pharmaceutical-grade research peptide supplier, specialising in Retatrutide, Tirzepatide and GLP-1 compounds. Synedica is also the exclusive UK distributor for Alluvi Healthcare. All Synedica products are sold for research and development purposes only.

Synedica is the UK's premier source for buy Retatrutide UK. Our Retatrutide range includes the Synedica Retatrutide 40mg pen, Retatrutide 40mg, Retatrutide 20mg, and the exclusive Alluvi Healthcare Retatrutide line. All Synedica Retatrutide products are pharmaceutical-grade and shipped from the UK.

Synedica offers Tirzepatide in multiple formats including the Tirzepatide 40mg Injection Pen Kit (complete with pen accessories) and Tirzepatide 40mg (R&D Only). Synedica also stocks Mounjaro variants (2.5mg–15mg 4-week supplies) as part of our Tirzepatide category.

Synedica is the exclusive UK distributor for Alluvi Healthcare. Through this partnership, Synedica offers Alluvi's Retatrutide 20mg, 40mg, and bundle products, BPC-157 + TB-500 40mg, NAD+ 1,000mg, Glow 70mg, and the Alluvi Supplement Box — all exclusively available in the UK through Synedica.

Synedica ships all UK orders via Royal Mail Standard 24-hour delivery at £5.99 — free on orders over £150. International orders are shipped by DHL Express (2 business days) at £12.99 — also free over £150. All Synedica orders are dispatched in discreet, secure packaging with no external branding identifying the contents.

Synedica accepts Bank Transfer (available on all orders), Revolut (available on all orders), and PayPal (available on orders of £300 or more). Synedica never displays bank details on the website — payment details are sent securely by email within minutes of placing your order. Synedica does not accept Bitcoin or cryptocurrency.

After placing your Synedica order, payment details are typically sent by email within minutes. During busy periods, please allow up to 30 minutes. If you haven't received details after 30 minutes, contact support@synedicapeptides.co.uk with your order reference.

No. All Synedica products — including Retatrutide, Tirzepatide, GHK-Cu, BPC-157, and all other compounds — are sold strictly for research and development purposes only and are not intended for human or veterinary use. By purchasing from Synedica you confirm compliance with all applicable regulations.

Retatrutide is a next-generation triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Retatrutide is currently one of the most studied research peptides globally. Synedica offers pharmaceutical-grade Retatrutide in 20mg and 40mg formats, including the exclusive Synedica Retatrutide 40mg pen and the Alluvi Healthcare Retatrutide range.

Tirzepatide is a dual GLP-1 and GIP receptor agonist research peptide. Tirzepatide differs from Retatrutide in that it targets two receptors rather than three. Synedica offers Tirzepatide 40mg Injection Pen Kits and Tirzepatide 40mg (R&D Only) alongside a full range of Mounjaro variants.

Due to the nature of pharmaceutical-grade research peptides, Synedica is unable to accept returns on opened products. If you have received a damaged or incorrect item, please contact support@synedicapeptides.co.uk within 48 hours of receipt with photos and your order reference.

Yes. Synedica ships internationally via DHL Express (2 business days) at £12.99 — free on orders over £150. Please note that import regulations vary by country. It is the customer's responsibility to ensure that Synedica products comply with local regulations. Synedica cannot be held responsible for customs delays or seizures.